The economic burden of psoriasis with high comorbidity among privately insured patients in the United States.

CONCLUSIONS: HRU and cost burden of psoriasis are substantial, and increase with development of psoriasis-related comorbidities.
PMID: 30523738 [PubMed - as supplied by publisher]

Source: Journal of Medical Economics - December 15, 2018 Category: Health Management Tags: J Med Econ Source Type: research